Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Wulf

Showing results (131-140 of 157) with videos related to

Pageof 16
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2011
Phase I/II study of trastuzumab in combination with everolimus (RAD001) in patients with HER2-overexpressing metastatic breast cancer who progressed on trastuzumab-based therapyPhuong K Morrow, Gerburg M Wulf, Joe Ensor, et al.
Plos Biology|June 21, 2018
Reporters to mark and eliminate basal or luminal epithelial cells in culture and in vivoOlmo Sonzogni, Jennifer Haynes, Laurie A Seifried, et al.
Cell|January 30, 2016
Phosphoinositide 3-Kinase Regulates Glycolysis through Mobilization of Aldolase from the Actin CytoskeletonHai Hu, Ashish Juvekar, Costas A Lyssiotis, et al.
Medrxiv : the Preprint Server for Health Sciences|January 23, 2024
Effect of testosterone therapy on breast tissue composition and mammographic breast density in trans masculine individualsYujing J Heng, Gabrielle M Baker, Valerie J Fein-Zachary, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2022
Mutational Signature 3 Detected from Clinical Panel Sequencing is Associated with Responses to Olaparib in Breast and Ovarian CancersFelipe Batalini, Doga C Gulhan, Victor Mao, et al.
JAMA Oncology|June 14, 2019
Open-label Clinical Trial of Niraparib Combined With Pembrolizumab for Treatment of Advanced or Metastatic Triple-Negative Breast CancerShaveta Vinayak, Sara M Tolaney, Lee Schwartzberg, et al.
Plant Biology (Stuttgart, Germany)|December 17, 2019
Plant functional trait response to environmental drivers across European temperate forest understorey communitiesS L Maes, M P Perring, L Depauw, et al.
Infection Control and Hospital Epidemiology|April 5, 2011
Highly resistant gram-negative microorganisms: incidence density and occurrence of nosocomial transmission (TRIANGLe Study)I Willemsen, S Elberts, C Verhulst, et al.
Breast Cancer Research : BCR|July 3, 2024
Effect of testosterone therapy on breast tissue composition and mammographic breast density in trans masculine individualsYujing J Heng, Gabrielle M Baker, Valerie J Fein-Zachary, et al.
Cell|November 12, 2013
Depletion of a putatively druggable class of phosphatidylinositol kinases inhibits growth of p53-null tumorsBrooke M Emerling, Jonathan B Hurov, George Poulogiannis, et al.
Pageof 16

Showing results (131-140 of 157) with videos related to

Sort By:
Pageof 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2011
Phase I/II study of trastuzumab in combination with everolimus (RAD001) in patients with HER2-overexpressing metastatic breast cancer who progressed on trastuzumab-based therapyPhuong K Morrow, Gerburg M Wulf, Joe Ensor, et al.
Plos Biology|June 21, 2018
Reporters to mark and eliminate basal or luminal epithelial cells in culture and in vivoOlmo Sonzogni, Jennifer Haynes, Laurie A Seifried, et al.
Cell|January 30, 2016
Phosphoinositide 3-Kinase Regulates Glycolysis through Mobilization of Aldolase from the Actin CytoskeletonHai Hu, Ashish Juvekar, Costas A Lyssiotis, et al.
Medrxiv : the Preprint Server for Health Sciences|January 23, 2024
Effect of testosterone therapy on breast tissue composition and mammographic breast density in trans masculine individualsYujing J Heng, Gabrielle M Baker, Valerie J Fein-Zachary, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2022
Mutational Signature 3 Detected from Clinical Panel Sequencing is Associated with Responses to Olaparib in Breast and Ovarian CancersFelipe Batalini, Doga C Gulhan, Victor Mao, et al.
JAMA Oncology|June 14, 2019
Open-label Clinical Trial of Niraparib Combined With Pembrolizumab for Treatment of Advanced or Metastatic Triple-Negative Breast CancerShaveta Vinayak, Sara M Tolaney, Lee Schwartzberg, et al.
Plant Biology (Stuttgart, Germany)|December 17, 2019
Plant functional trait response to environmental drivers across European temperate forest understorey communitiesS L Maes, M P Perring, L Depauw, et al.
Infection Control and Hospital Epidemiology|April 5, 2011
Highly resistant gram-negative microorganisms: incidence density and occurrence of nosocomial transmission (TRIANGLe Study)I Willemsen, S Elberts, C Verhulst, et al.
Breast Cancer Research : BCR|July 3, 2024
Effect of testosterone therapy on breast tissue composition and mammographic breast density in trans masculine individualsYujing J Heng, Gabrielle M Baker, Valerie J Fein-Zachary, et al.
Cell|November 12, 2013
Depletion of a putatively druggable class of phosphatidylinositol kinases inhibits growth of p53-null tumorsBrooke M Emerling, Jonathan B Hurov, George Poulogiannis, et al.
Pageof 16